Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Hypertrophic Cardiomyopathy: early-phase trial registry
6 of 12 indexed Hypertrophic Cardiomyopathy trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,429 of 28,707 conditions by registered trial count.
12 US clinical trials · 6 currently recruiting · #1,429 of 28,707 conditions by registered trial count
Hypertrophic Cardiomyopathy: 12 US clinical trials tracked, 6 recruiting.
Hypertrophic Cardiomyopathy is the subject of 12 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Mayo Clinic, running 2 of these trials.
Enrollment posture brief
Registry condition hypertrophic-cardiomyopathy
OPEN 6 | RECR 50% | LATE 0 | EARLY 2 | RANK #1429 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Hypertrophic Cardiomyopathy lists 6 open slots (50% of 12 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Hypertrophic Cardiomyopathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Hypertrophic Cardiomyopathy is recruiting above its size-band peers.
6 of 12 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Hypertrophic Cardiomyopathy research.
Mayo Clinic accounts for 2 of 12 trials (16.7%). 11 distinct sponsors appear on at least one study for this condition label.
-
Typical Hypertrophic Cardiomyopathy enrolment sits around 260 participants.
Median target enrolment is 260 among the 11 trials that report a genuine target (sentinel values excluded). 3 of those (27.3%) plan for fewer than 100 participants.
-
Hypertrophic Cardiomyopathy research leans observational.
3 interventional and 9 observational studies make up this index (25% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
12 total, page 1 of 1
Cardiovascular Multimodality Imaging Study
Montefiore Medical Center
NCT06610019
VIZ ACCESS HCM - Multi-Site Registry
Viz.ai
NCT07103057
Pediatric Cardiomyopathy Mutation Analysis
Indiana University
NCT02432092
Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy
University of California, San Francisco
NCT05818605
Multi-center, Open-label, Single-ascending Dose Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM
Tenaya Therapeutics
NCT05836259
Mavacamten Pregnancy Surveillance Program
Bristol-Myers Squibb
NCT05939700
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
University of Virginia
NCT01915615
A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy
Mayo Clinic
NCT04112290
A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete's
Mayo Clinic
NCT06290570
A Study of EDG-7500 in Adults With Hypertrophic Cardiomyopathy (CIRRUS-HCM)
Edgewise Therapeutics
NCT06347159
Exercise in Genetic Cardiovascular Conditions
Yale University
NCT02549664
Screening for Inherited Heart Disease
National Heart, Lung, and Blood Institute (NHLBI)
NCT00001746
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Hypertrophic Cardiomyopathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Hypertrophic Cardiomyopathy trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Hypertrophic Cardiomyopathy page
12 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Hypertrophic Cardiomyopathy trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Mayo Clinic sponsors the most Hypertrophic Cardiomyopathy trials on record, review their full trial history before evaluating a specific study. See Mayo Clinic's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Hypertrophic Cardiomyopathy condition card totals 12 registered trials; most-linked intervention AliveCor KardiaMobile 6-Lead ECG; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.